首页> 外文期刊>International Urology and Nephrology >Vascular adhesion protein-1 in hemodialysis and hemodiafiltration patients: effect of single hemodialysis session on its level in regard to type of anticoagulant
【24h】

Vascular adhesion protein-1 in hemodialysis and hemodiafiltration patients: effect of single hemodialysis session on its level in regard to type of anticoagulant

机译:血管性粘附蛋白-1在血液透析和血液透析患者中:单一血液透析会话对抗凝剂类型的血液透析会

获取原文
获取原文并翻译 | 示例
           

摘要

Traditional anticoagulants used in intermittent hemodialysis (HD) are unfractionated heparin (UFH) and increasingly low molecular weight heparins (LMWHs). Repeated and prolonged exposure to UFH and/or LMWHs may further disturb hemostasis in uremic patients. Vascular adhesion protein-1 (VAP-1) is secreted by vascular smooth muscle cells, adipocytes and endothelial cells with functional monoamine oxidase activity and is elevated in atherosclerosis, diabetes mellitus and obesity. The aim of this study was to assess the effects of UFH and LMWHs on VAP-1 concentration in HD patients. The effects on single HD session on VAP-1 were also evaluated as well as VAP-1 levels in regard to type of renal replacement therapy.
机译:间歇性血液透析(HD)中使用的传统抗凝血剂是未分割的肝素(UFH)和越来越低的分子量肝素(LMWH)。 重复和长时间暴露于UFH和/或LMWH,可能进一步扰乱尿毒症患者的止血。 血管粘合蛋白-1(VAP-1)由血管平滑肌细胞,脂肪细胞和内皮细胞分泌,具有功能性单胺氧化酶活性,在动脉粥样硬化,糖尿病和肥胖症中升高。 本研究的目的是评估UFH和LMWHS对高清患者VAP-1浓度的影响。 还评估了对VAP-1上单高清会议的影响以及肾置换疗法类型的VAP-1水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号